2023 annual financial data

Corbus Pharmaceuticals Holdings 2023 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -45.08M USD and net income was -44.6M USD.
Operating cash flow was -36.1M USD.

Get free Corbus Pharmaceuticals Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-45.08M USD
Net income
-44.6M USD
Operating cash flow
-36.1M USD